Increasing Use of Compassionate Use/Managed Access Channels to Obtain Medicines for Use in COVID-19.

Aliu P., Sarp S., Fitzsimmons P.

DOI

10.1002/cpt.2140

Type

Journal article

Publication Date

2021-07-01T00:00:00+00:00

Volume

110

Pages

26 - 28

Total pages

2

Keywords

COVID-19, Compassionate Use Trials, Drug Approval, Drug Repositioning, Drug and Narcotic Control, Drugs, Investigational, Emergency Medical Services, Health Services Accessibility, Humans, Internationality, Physician's Role, Risk Assessment, SARS-CoV-2, COVID-19 Drug Treatment

Permalink More information Close